<DOC>
	<DOCNO>NCT00831129</DOCNO>
	<brief_summary>The purpose research study examine combination cholesterol lowering-drug , simvastatin , sugar-lowering drug call rosiglitazone effective improve vascular inflammation ( irritation vessel transport blood ) cardiovascular risk factor take simvastatin alone .</brief_summary>
	<brief_title>A Study Pre-diabetic Patients With Cholesterol Lowering Drugs</brief_title>
	<detailed_description>Age 21-75 year Metabolic syndrome ( must 3 5 component ) elevate waist circumference &gt; 40inches men , &gt; 35 inch woman elevate triglyceride &gt; 150mg/dL reduced HDL &lt; 40mg/dL men &lt; 50 woman elevate blood pressure &gt; 130mmHg systolic , &gt; 85mmHg diastolic elevate fast glucose &gt; 100mg/dL</detailed_description>
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Rosiglitazone</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>2175 year Metabolic syndrome ( 3 5 component ) Elevated waist circumference &gt; 40inches men , &gt; 35inches woman Elevated triglyceride &gt; 150mg/dL Reduced HDL &lt; 40mg/dL men , &lt; 50mg/dL woman Elevated blood pressure &gt; 130mmHg systolic , &gt; 85mmHg diastolic Elevated fast glucose &gt; 100mg/dL Diabetes mellitus Stage 3 hypertension &gt; 180mmHg systolic , &gt; 110mmHg diastolic office blood pressure History nondiabetic kidney disease Myocardial infarction unstable angina within past 6 month History liver disease History malignancy History drug alcohol abuse Treatment corticosteroid Pregnancy lactate woman woman child bear potential willing use reliable contraception method study</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>